We study how the brain uses cell-type-specific epigenetic mechanisms to encode external inputs as memories, and how these processes fail in aging and disease.
Neuroepigenetics of brain physiology and pathology Lab
Was a pleasure to present the EpiFlow platform at #EMBOBrainEpi, great meeting! Congrats to the organizers and @embo.org #EpiFlow #Neuroepigenetics #epigentics #singlecell #flowcitometry
Happy to share our first preprint! Led by @joseruiziglesias.bsky.social — EpiFlow: multidimensional single-cell epigenetic profiling by spectral flow cytometry
Many thanks to @cbm-csic-uam.bsky.social, @ageinves.bsky.social and Fundación Ramón Areces for their support
www.biorxiv.org/content/10.6...
Neuroepigenetics of brain physiology and pathology Lab
The epigenetic landscape of individual cells determines their identity and function, yet current methods for profiling chromatin modifications at single-cell resolution remain low-throughput, costly, or limited in parametric depth. Here we present EpiFlow, a spectral flow cytometry-based platform that enables the simultaneous quantification of 16 epigenetic markers, including histone post-translational modifications, DNA methylation, and hydroxymethylation, at the single-cell level. We demonstrate that EpiFlow is robust across species from yeast to mammals and resolves biologically meaningful epigenetic transitions during the cell cycle, stem cell differentiation, germinal centre B cell maturation, diabetic liver remodelling, and seizure-induced chromatin reprogramming. High-dimensional integration of EpiFlow data enables cell-type classification based solely on epigenetic profiles in liver, brain, blood, and cancer. Furthermore, EpiFlow detects on-target and off-target/indirect effects of epigenetic drugs in a high-throughput-compatible format. Collectively, these results establish EpiFlow as a broadly applicable platform for single-cell epigenetic analysis in basic, pharmaceutical, and translational research. ### Competing Interest Statement The authors have declared no competing interest. Agencia Estatal de Investigación, PID2022-137384OA-I00 (ERDF /EU), RYC2021-031713-I (European Union NextGenerationEU/PRTR), EUR2024-153539, CNS2024-154632 Fundación Ramón Areces, CIVP22A7609
